MedTrace Logo

Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals

NCT04449653 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-06-29

No results posted yet for this study

Summary

OASIS: A mobile study to measure and predict lupus (SLE) disease activity using digital signals The OASIS study is exploring how patient reported data and digital biomarkers, like activity level and heart rate variability, can be used to predict changes in lupus disease activity. You may receive a Withings Steel HR smartwatch as part of this study. The purpose of this study is to look for factors that affect lupus disease activity and potentially predict lupus flares through non-clinical tests

Conditions

  • Lupus Erythematosus, Systemic
  • Lupus Erythematosus

Sponsors & Collaborators

  • Progentec Diagnostics, Inc.

    lead INDUSTRY

Principal Investigators

  • Eldon Jupe, Ph.D. · Progentec Diagnostics

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-28
Primary Completion
2020-12-31
Completion
2021-06-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04449653 on ClinicalTrials.gov